US Stock MarketDetailed Quotes

GNFT Genfit

Watchlist
  • 3.798
  • +0.083+2.24%
Trading Jan 2 13:57 ET
189.56MMarket Cap9.92P/E (TTM)

About Genfit Company

Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-Fran?ois Mouney, Florence Séjourné, and Bart Staels in September 1999 and is headquartered in Loos, France.

Company Profile

SymbolGNFT
Company NameGenfit
Listing DateMar 27, 2019
Issue Price20.32
Founded1999
CEOMr. Pascal Prigent
MarketNASDAQ
Employees159
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressParc Eurasante,885, Avenue Eugène Avinée,Lille Métropole
CityLoos
ProvinceHF
CountryFrance
Zip Code59120
Phone33-3-20-16-40-00

Company Executives

  • Name
  • Position
  • Salary
  • Pascal Prigent
  • Chief Executive Officer
  • --
  • Pascal Caisey
  • Chief Operating Officer
  • --
  • Dr. Meriam Kabbaj, PhD
  • Chief Technology Officer
  • --
  • Carol Addy
  • Chief Medical Officer
  • --
  • Thomas Baetz
  • Chief Financial Officer
  • --
  • Jean-Christophe Marcoux
  • Chief Corporate Affairs Officer, Head of Investor Relations and Head of ESG
  • --
  • Stefanie Magner
  • Chief Compliance Officer and Executive Vice President, International Legal Affairs
  • --
  • Dean Hum, PhD
  • Chief Scientific Officer
  • --
  • Emilie Desodt
  • Executive Vice President, Human Resources
  • --
  • Sayah-Jeanne Sakina
  • Executive Vice President, Research and Translational Science
  • --
  • Tom Huijbers
  • Executive Vice President, Regulatory
  • --
  • John Brozek
  • Executive Vice President, Data and Information Technology
  • --
  • Jean-Francois Mouney
  • Chairman of the Board
  • --
  • Xavier Guille des Buttes
  • Vice Chairman of the Board
  • --
  • Sandra Silvestri
  • Director
  • --
  • Florence Sejourne
  • Director
  • --
  • Laurent Lannoo
  • Corporate Secretary and Director of Legal Affairs
  • --
  • Anne-Helene Monsellato
  • Independent Director
  • --
  • Jean-Francois Tine
  • Independent Director
  • --
  • Dr. Catherine Larue, PhD
  • Independent Director
  • --
  • Eric Baclet
  • Independent Director
  • --
  • Katherine Bach Kalin, M.B.A.
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data